A recent study utilizing cryo-EM advances our understanding of how bacterial immune systems function and reveals new aspects ...

A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way ...

Using a CRISPR-based biosensor platform, researchers have detected microRNA biomarkers of Alzheimer’s disease, with the ...

Emerging research in cellular reprogramming, gene editing, and regenerative medicine is driving interest in preventive longevity medicine. Some researchers argue aging may be treated as a modifiable ...

Kiana Aran, Associate Professor of Bioengineering and Medicine at the University of California San Diego, spoke with Rudra Chaudhuri, Vice President of the Observer Research Foundation, at the Raisina ...

Now, it’s worth noting Stock Advisor’s total average return is 892 % — a market-crushing outperformance compared to 194% for the S&P 500. Don't miss the latest top 10 list, available with Stock ...

If you are wondering whether CRISPR Therapeutics at around US$53.52 is offering good value today, you are not alone. The stock often attracts investors who care about price versus potential. The share ...

These two biotechs have a lot in common. Their differences are even more pronounced.

Cocaine addiction isn’t simply a failure of willpower — it’s the result of lasting biological changes in the brain.

A new study has uncovered why some brain cells are more resistant to Alzheimer’s damage than others. Researchers found a natural cleanup system that helps remove toxic tau protein before it can form ...

Scientists generate world’s first ’extraordinary aromatic tomato plants’ by simultaneously altering two key genes ...

Using prime editing, NCF1 mutation is corrected in a 19-year-old with chronic granulomatous disease, an inherited immune disorder, marking a gene therapy milestone.